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“3D” Ultrasound Works!
But There Is Work to Be Done*Tasneem Z. Naqvi, MDSEE PAGE 1065I maging-based assessment of atherosclerosis topredict incident cardiovascular disease (CVD)instead of a risk factor–based approach has been
proposed as a way to implement preventive interven-
tion and thwart the increasing CVD toll (1). Intima-
media thickness (IMT) of exposed large vessels, such
as the carotid arteries, predicts future CVD better
than risk factors alone (2). However, wide variability
in ability of IMT to predict future CVD events was
found amongst studies, leading to uncertainty re-
garding its utility (3), which is reﬂected in consensus
statements and guidelines. The 2010 American College
of Cardiology/American Heart Association (ACC/AHA)
guidelines (4) gave carotid IMT assessment a Class IIa
(beneﬁt greater than risk) indication in subjects with
intermediate-risk Framingham Risk Scores (FRS),
whereas the 2013 guidelines gave it a Class III indica-
tion (should not be done) (5).
Subsequent studies showed that focal atheroscle-
rosis deﬁned by plaques conferred a higher CVD risk
than IMT (6–8). The published reports (3,4,9,10) show
that if an ultrasound (US) IMT imaging protocol is less
comprehensive or excludes assessment of plaque, its
predictive power is weakened. More recent studies
IMT has been shown to have a much weaker predic-
tive power for CVD events than coronary artery
calciﬁcation (CAC) (11,12). However, 2-dimensional
(2D) IMT and binary assessment of plaque only cap-
tures an incomplete image of atherosclerosis, as
compared to the 3-dimensional (3D) assessment of*Editorials published in the Journal of the American College of Cardiology
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tomography.
2D carotid plaque area performed far better than
IMT assessment in the prediction of ischemic stroke
in a large cohort of adults (13). Assessment of 3D
plaque area by US would be better than 2D plaque
area method to quantify atherosclerosis, however, no
study has demonstrated whether assessment of pla-
que burden by 3D US is feasible and accurate enough
compared with a direct 3D assessment of coronary
plaque by CAC for prediction of CVD events.The BioImage Study by Baber et al. (14) in this issue
of the Journal is a landmark large, prospective study
of asymptomatic men and women (N ¼ 7,687, age
69  6 years) that assessed total carotid artery plaque
burden using both a modiﬁed “3D” US assessment of
bilateral carotid arteries CAC. The purpose was to
predict near-term (3-year) atherothrombotic events
by comparing imaging biomarkers from 2 different
vascular beds. The results showed that 3D carotid
plaque burden was comparable to CAC plaque burden
in predicting death and myocardial infarction, as well
as angina and coronary revascularization, over a
mean 2.7-year follow-up. If conﬁrmed, these results
may have broad implications, because US is readily
available, portable, without risk, readily repeatable,
and does not expose patients to radiation.
Importantly, in the current study, 60% of the
overall study cohort and one-half of the low-FRS
subjects had an atherosclerotic burden by either
imaging test—a sobering statistic. Both CAC and 3D
carotid US reclassiﬁed individuals far better than the
risk factor–based approach and had a similar clinical
net reclassiﬁcation index. More than 40% of subjects
with intermediate FRS and up to 12% of subjects
with any FRS were classiﬁed appropriately as higher
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atherosclerosis. Reassuringly, both tests reclassiﬁed
over one-half of the patients in whom events did not
occur as low risk across all FRS categories (3,152 by
CAC and 2,792 by plaque of 5,726 subjects). In the low-
risk and intermediate-risk cohorts, deﬁned by FRS or
by the new pooled cohort equation, without events,
US overclassiﬁed patients as higher-risk compared
with CAC. However, among the 82 subjects in whom
primary events occurred and 216 subjects in whom
secondary events occurred, each test classiﬁed a third
of subjects as low risk. An important ﬁnding is the
incremental impact of systemic atherosclerosis on
short-term risk. Thus, the presence of atherosclerosis
in 2 vascular beds conferred a higher risk than in 1 bed
alone, and across all risk categories, the gradient of
risk between increasing CAC or plaque remained in-
dependent of one another and of risk factors.
There are limitations to the study by Baber et al.
(14). The primary endpoint occurred in only 82 (1.5%)
of the study cohort and secondary endpoint in 216
(4.2%). This low event rate is related to a short follow-
up (mean 2.7 years) and probable risk modiﬁcation as
a result of statin use during enrollment, which was
not detailed in the study. The plaque assessment was
not real-time 3D using a 3D transducer, but a combi-
nation of 2D images obtained from a 2D transducer
(with attendant increased post-processing times),
because true 3D methods were not fully developed at
the start of the study. In addition, plaque was only
assessed in the short-axis views, which may miss or
poorly quantify plaque in tortuous or deep vessels,
and may not delineate medial and lateral wall plaques
because of the poor lateral resolution of US. Recent
data show that direct 3D assessment and quantiﬁca-
tion of carotid plaque is feasible and can be used
clinically (15). An unanswered question is whether
the imaging-based results would change in younger
subjects who have not yet developed plaque calciﬁ-
cation, but have noncalciﬁed plaque that is detectable
by US. The threshold of signiﬁcance for plaque
burden and the effect of aging on this threshold also
remain unclear, and should be addressed by further
studies. In addition, any conclusions drawn from the
study by Baber et al. (14) apply in the short term, only
to short-term adverse events of atherothrombosis andmay be different if the subjects were followed longer
term. In particular the predictive ability of both tests
may diverge with longer follow up, considering that a
higher percent of subjects with lower and interme-
diate FRS were classiﬁed by ultrasound as higher risk
compared to CAC.
How should these new imaging modalities be used?
On the basis of data from this study, direct imaging
assessment of atherosclerosis in at least 1 vascular bed
is far superior to a risk factor–based approach in
allocating middle-aged to older individuals to the
correct CVD risk category. Because of the lack of
radiation, US imaging may be more suitable for
longitudinal life-long surveillance if no plaque burden
is identiﬁed in either vascular bed at baseline and
may be a ﬁrst-line test in younger individuals and in
women in whom plaque calciﬁcation may not have
developed, although the current study in an older
cohort of subjects does not address this question.
The new Framingham Cohort Equations would
recommend nearly 50% of U.S. adults for statin
therapy (16). Would this be safer, more cost effective,
and reduce CVD death rates compared with an
imaging-based approach that correctly reclassiﬁed
more than 40% of subjects with intermediate FRS?
The future of 3D US is bright, with expected near-
term improvements in frame rate and online data
processing availability. This would provide a faster,
more accurate, and repeatable test to detect and
quantify atherosclerosis in its earliest stages, as well
as monitor treatment effects on atherosclerosis in
individual patients. Longer-term follow-up data from
the current study and future studies using real-time
3D US would be of great interest. In the meantime,
the study by Baber et al. (14) brings an imaging-based
approach for detecting individuals at higher risk of
future CVD closer to clinical application.
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